Viewing Study NCT05999604

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:16 PM

Ignite Modification Date: 2026-01-04 @ 4:57 AM

Study NCT ID: NCT05999604

Status: RECRUITING

Last Update Posted: 2025-09-29

First Post: 2023-08-11

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module